Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment

The rapid evolution of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are regarded as potential drug targets due to their dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zu, Mian, Li, Chao, Fang, Jian-Song, Lian, Wen-Wen, Liu, Ai-Lin, Zheng, Li-Shu, Du, Guan-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332427/
https://www.ncbi.nlm.nih.gov/pubmed/26540031
http://dx.doi.org/10.3390/molecules201119653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332427/
https://www.ncbi.nlm.nih.gov/pubmed/26540031
http://dx.doi.org/10.3390/molecules201119653

Ejemplares similares